Anxiety.
Conditions
Interventions
Intervention 1: Intervention group: Two identically shaped packages of Monzeg-e-Soda Capsules (containing 100 tablets) are delivered to the patient for a period of 60 days, along with a medication che
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Infertile men with defects in the quantity (in terms of volume) and quality of semen (in terms of number, shape, and motility) of mild to moderate severity according to a spermogram test performed on two men 2 to 3 months apart Having symptoms of anxiety Age between 20 and 50 years Informed consent to enter the study Have not received specific treatment for anxiety for at least three months. The severity of the person's anxiety disorder is not severe and is mild to moderate.
Exclusion criteria
Exclusion criteria: Patients with acute renal failure based on paraclinical and clinical symptoms Patients with uncontrolled blood pressure Chronic patitis, liver cirrhosis, and hepatic cholestasis according to clinical and paraclinical symptoms Long-standing and uncontrolled diabetes according to clinical and paraclinical symptoms Drug allergy or any drug reaction to the active ingredients of soda or placebo. People who use anti-anxiety medications during the study. People who use anti-anxiety medications during the study. Patients with azoospermia according to spermogram test. People taking corticosteroids. People taking digoxin. People taking anticoagulants, antiplatelets, and thrombolytics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety severity. Timepoint: Before the intervention and after the end of the intervention (8 weeks). Method of measurement: Spielberg Anxiety Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoshanak Mokaberi Nejad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed